The dose dependent depletion of ovarian Ascorbic acid (AA) in rat ovaries, has been used as a bioassay for measurement of Luteinizing Hormone (LH). However, the mechanism of action of gonadotropin (LH, FSH) on ascorbic acid depletion is not completely clear in biochemical terms. To elucidate the mechanism, we looked for the pathways; one, where L-Gulonate Dehydrogenase (L-GuDH) catalyzes the conversion of L-Gulonic acid (L-GuA) to L-Xylulose, and, in the second the pathway conversion of L-GuA to AA, in a cats, dogs and Rats. Kinetic analysis of the enzyme L-GuDH in vitro showed the inhibitory effect of AA on L-GuDH.
Introduction
The gonadotropins, FSH (Follicle Stimulating Hormone) and LH (Luteinizing Hormone) secreted by anterior pituitary gland in response to intrinsic as well as extrinsic influences, stimulate a variety of ovarian functions including steroidogenesis, resumption of oocyte meiosis, ovulation, maintenance and formation of corpus luteum (Lindner et al. 1974) . In males, the role of LH is mainly to control the synthesis and secretion of testosterone by Leydig cells. In females, it plays crucial role in ovulation and sustenance of the corpus luteum in the luteal phase of the female reproductive cycle (Dufau 1998) . FSH is indispensable for both male and female gametogenesis. Pregnant Mare Serum Gonadotropins (PMSG) is a glycoprotein hormone secreted from endometrial cups of pregnant mare following 35 days of gestation (Papkoff 1974) .PMSG exhibits both LH and FSH activities in heterologous animal species (Cole et al. 1940; Combarnous 1992) while being mostly LH like in equids (Urwin & Allen 1982) . In the immature male rat, PMSG increases testicular weight, the enlargement of seminal vesicles (Cole et al. 1932; Raacke et al. 1957) The dual function of this placental gonadotropin has generated extensive interest with regard to mechanism of action in vivo (Licht et al. 1979; Moudgal & Papkoff 1982) . The function of gonadotropins, (LH and FSH) and thyrotropin has been found to be mediated through the second messenger cyclic AMP (Moudgal et al. 1971) .
Gonadotropins have also been shown to elicit some non-steroidogenic responses from the ovaries like incorporation of Uridine to RNA, and incorporation as well as transport of proteins into ovary or increasing the poly A length of ovarian transcripts (Ahren, K, Hamberger, L, Rubinstein 1969; Jarlstedt et al. 1973; Selstam & Nilsson 1974; Prasad et al. 1978) . One of oldest and the most widely used bioassays for LH measurement by LH induced depletion of ovarian ascorbic acid in super-ovulated immature rats, first observed by Parlow (Parlow 1961) .
Some factors other than LH also influence ascorbic acid level in ovaries (Miszkiel 1999) .
Vasopressin also possesses appreciable activity like that of LH (Mccann & Taleisnik 1960) .
Purified preparation of other anterior pituitary hormones failed to affect the levels of ascorbic acid in ovary (Mccann & Taleisnik 1960; Schmidt-Elmendorf & Loraine 1962) . In animals like rat and mice it could be proposed that LH must be affecting, either biosynthesis or catabolism or both, of ascorbic acid in the ovary. Another possibility is that LH may be accelerating transfer of ascorbic acid from ovary to venous circulation. Ascorbic acid metabolism involves more than one metabolic pathway. In the biosynthetic pathway of ascorbic acid, Lgulonolactone get converted to L-ascorbic acid via 2-keto-L-gulonolactone and the latter reaction is catalyzed by L-gulonolactone oxidase (gulo) (Chatterjee et al. 1960) . In the animals such as mice and rats that are capable of synthesizing AA, therefore, two pathways are Under special condition, it is possible that L-GuDH is blocked, thus formation of xylitol is blocked and hence ascorbic acid concentration is increased. Does such a scenario happen in reverse in ovary? (Figure 1 ). How is the depletion of ovarian AA by LH regulated? Is there any role of L-GuDH in the regulation of AA depletion?. Vitamin C or ascorbic acid has been found to play an important role in reproductive process (Kramer et al. 1933) . Parlow had shown the gonadotropin action of LH on ovarian ascorbic acid content in 1961, where he observed that there was marked decrease in ovarian ascorbic acid in the corpus luteum and possibly during lutenization itself (Parlow 1961) . In order to explore the association between L-GuDH, ascorbic acid and hormonal action, we initiated the study by using rat model, in which we performed commonly used bioassay called Ovarian Ascorbic Acid Depletion Assay (OAAD) or Parlow bioassay.
Materials and Methods

Animals
Animal experiments were carried out according to the guidelines of CPCSEA,'' Government of India, with Institutional Animal Ethics Committee IAEC approval DUZOO/IAEC-R/2011/17. Rats were of the Holtzman strain, housed in our animal house under controlled temperature (21-23°C) and with the light period adjusted to 12 h light and 12 h darkness. The animals had free access to standard pelleted laboratory animal food and tap water.
Chemicals and Hormones
L-Gulonate-γ-lactone, NAD, PMSG, hCG, 2,6 dichloro phenol indophenol (monosodium salt)(DCPIP), theophylline and L-ascorbic acid were purchased from Sigma USA. All other chemicals used were of analytical grade
Estimation of Protein
Protein estimation of the samples was performed at each step, according to the method given by Lowry (Lowry et al. 1951) .
Effect of hCG (LH like hormone) on ovaries
Super ovulated immature female rats of Holtzman strain 26-28 days old were used for the experiments. Rats were made super ovulated by injecting 50IU of PMSG (in 0.2ml of albumin phosphate buffer) subcutaneously twice 48 hours apart. 56 to 60 hours later the animals received 25IU of hCG in 0.2ml of albumin phosphate buffer again subcutaneously. On the 6 th day after the injection of hCG the animals were used for the experiment. On the day of experiment animals were divided into two groups control and experimental, 3 animals (n=3) in each group. The control animals received only albumin phosphate buffer and experimental animals received 60IU hCG in 0.2ml of albumin phosphate buffer intraperitoneally. Four hours later, the animals were taken for autopsy. Left ovaries were used for AA estimation and right ovaries for L-GuDH assay. Placing the ovaries on an ice-chilled Petri dish containing 5% metaphosphoric acid to stop the metabolic activities did subsequent processing for left ovary.
The ovary was freed of surrounding adipose tissue and quickly weighed to the nearest mg precision balance. Slightly minced ovarian tissue was then homogenized in 3ml of 5% metaphosphoric acid-citrate solution, using a Potter-Elvehjem Teflon tissue grinder. The homogenate was then centrifuged at 10000 rpm for 30min at 4⁰c using a cold centrifuge (SIGMA). An aliquot of 3mL from the clear supernatant was used for the estimation of AA according as follows.
A standard calibration curve was constructed using 0-80 µg of ascorbic acid in 2 mL of 5% metaphosphoric acid-citrate solution. 2 mL of the dye solution DCPIP was delivered quickly into the tubes mixed well and absorbance was read at 540nm at 20 th ± 2 seconds after mixing in the spectrocolorimeter. Ovarian ascorbic acid was estimated essentially as per the assay of Parlow (Parlow 1961 ).
Effect of PMSG (FSH like hormone) on ovaries
For the experiment, 25-26 day old immature female rats (Holtzman strain) were used. Two groups of animals were taken, 4 animals (n=4) in each group. The control animals received only albumin phosphate buffer subcutaneously while the experimental group of animals received a single injections of 50IU of PMSG. Two days later, animals were sacrificed. The left ovary was processed for the ascorbic acid estimation and RNA extraction while the right ovary was processed for the enzyme assay and protein estimation. After autopsy the right ovaries of the rats were immediately removed. Subsequent processing of right ovaries was 7 done by placing the ovaries on an ice-chilled Petri dish having 50mM PB, pH 7.5 which contained 1mM PMSF (Extraction buffer). The ovary was freed of surrounding adipose tissue and quickly weighed to the nearest mg precision balance. Slightly minced ovarian tissue was then homogenized using a Potter-Elvehjem Teflon tissue grinder in 50mM PB, pH 7.5 containing 1mM PMSF. Finally the homogenate was centrifuged at 10000 rpm for 30 min at 4⁰c using a cold centrifuge (SIGMA make). An aliquot of 1mL from the clear supernatant was used for the assay of GuDH and protein estimation.
Measurement of L-GuDH Activity
L-GuDH the dehydrogenase activities of each samples of the bioassay were assayed by measuring the rate of change in NADH absorbance at 340 nm as described above. The amount of NADH produced as a result of dehydrogenase activity was calculated from the slopes of the curves obtained by change in absorbance against time interval at 340 nm as dictated by the assay method. Considering 6.220 as the micro molar extinction coefficient of NADH quantitated the units of GuDH present in one mL.
A340 × volume of enzyme solution ( mL) U/mL = 6.220 × T(min) × volume of enzyme solution taken for assay (mL) Δ Δ Specific activity or was calculated by dividing the value of U/mL by the concentration of protein.
U/mL Specific activity (U/mg) = mg/mL
Gene expression profiling following exposure to PMSG 
RNA Labelling, Amplification and Hybridization
The samples were labeled using Agilent Quick-Amp labeling kit (Part number: 5190-0424).
500ng of total RNA was reverse transcribed using oligo dT based method. mRNA was primed with oligo dT primer tagged to T7 promoter sequence and converted into double stranded cDNA using MMLV-RT reverse transcriptase. Further, in the same reaction cDNA was invitro transcribed to cRNA using T7 RNA polymerase enzyme. During cRNA synthesis, Cy3
labeled Cytosine nucleotide was incorporated into the newly synthesized strands. Labeled cRNA thus obtained was cleaned up using Qiagen RNeasy columns (Qiagen, Cat No: 74106) .
The concentration and amount of dye incorporated were determined using Nanodrop. 600ng of labeled cRNA were hybridized on the array (AMADID: 28279) using the Agilent Gene Expression Hybridization kit (Part Number 5190-0404) in Sure hybridization Chambers (Agilent) at 65ºC for 16 hours. Hybridized slides were washed using wash buffers (Part No:
5188-5327; Agilent). The hybridized and washed microarray slides were then scanned on a G2505C scanner (Agilent Technologies).
Feature Extraction
Data extraction from Images was done using Feature Extraction software Version 11.5.1.1 of Agilent.
Microarray Data Analysis
Images were quantified using Feature Extraction Software (Version-11.5, Agilent). Feature extracted raw data was analyzed using Gene Spring GX Version 12.0 software from Agilent.
Normalization of the data was done in Gene Spring GX using the 75th percentile shift 
Results and Discussion
The ovarian ascorbic acid depletion assay devised by Parlow (1961) is one of the most potent and reliable bioassays for LH. The calibration curve for ascorbic acid estimation showed that the method works well in the range of 0 to 80µg of ascorbic acid. (Figure 1) A significant depletion of ascorbic acid content was observed in experimental group as compared to control group (Table1). With respect to the control animal 60IU hCG administered animals had ascorbic acid content depleted up to 65.13%. One of the known actions of pituitary Lutropin (Luteinizing hormone) is to cause depletion of ovarian ascorbate in the pseudo-pregnant rat (Parlow 1961) . However, the actual role of AA in LH induced ovulation is not clearly known. The depletion of ovarian ascorbate by lutropin has been utilized as a sensitive bioassay of lutropin. This is reported to occur in corpora lutea within minutes of lutropin injection and exhibits a characteristic time sequence (Goldstein & Sturgis 1961) .Role of vitamin C has been observed in steroidogenesis and peptide hormone production (Luck et al.
1995).
When the enzyme (L-GuDH) was assayed, it was observed that the rate of change in absorbance of NADH with respect to time at 340nm remained almost same in control and experimental groups in both the trials (Figure 2) . NADH represents the activity of GuDH.
Further, the difference in Nano moles of NADH formed per minute per 100mg of ovarian weight or per mg protein, in experimental and control groups, was not significant (data not shown). Hence it can be concluded that LH does not regulate the activity of L-GuDH in the ovary. It was also observed that this effect of LH was Cyclohexiimide insensitive (Arora et al. 2012) . Therefore induced or constitutive protein synthesis is not required for this depleting effect of LH on ovarian ascorbic acid. Earlier work had shown that the administration of LH to Parlow rats results in increase in ovarian content poly A rich RNA (Muralidhar et al. 1976; Prasad et al. 1978) and that this effect could be observed within 30 minutes of LH administration. Hence the effect of LH on rat ovary appears to be both metabolic (non-genetic) and developmental (genetic) depending on the animal model..
In the experiment on effect of PMSG on rat ovarian ascorbic acid content, however, results indicate that administration of PMSG (a long acting FSH-like hormone) resulted in increase in gonado-somatic index ( Figure 3A) and increase in ascorbic acid content ( Figure 3B ). Further, the same treatment also resulted in increase in enzyme activity ( Figure 4A ), total protein content ( Figure 4B ) and in specific activity ( Figure 4C ). It is known that during follicular growth ovulation and formation of corpora lutea ECM undergoes constant changes, so it requires high level of collagen and ascorbic acid fulfills this demand by promotion of biosynthesis of collagen (Kramer et al. 1933) . The elevation in ascorbic acid levels can be explained by this mechanism. Growing corpus luteum requirement of collagen is fulfilled by ascorbate as it serves as a cofactor in collagen synthesis (Luck et al. 1995) . So ascorbic acid is playing direct role in the function of corpus luteum. (Byrd et al. 1993) .
Ascorbic acid inhibits the L-Gulonate dehydrogenase in in vitro condition (Sharma et al. 2013) .
It was interpreted that the high levels of ascorbic acid inhibited the enzyme in vivo. However molecular docking studies also indicate that ascorbic acid can bind GuDH (unpublished work).
It was also observed that there was no increase in specific activity of ovarian L-Gulonic acid dehydrogenase (L-GuDH) activity during the decrease in ascorbic acid under in vivo conditions. In the case of FSH action, however, simultaneous increase in both ascorbate levels and L-Gulonate dehydrogenase activity (Figure 3 and 4) was observed.
To understand the regulatory mechanism of FSH and LH on Ascorbic acid and L-GuDH, it is imperative to explore different pathways and the genes involved in ovarian functions. Hence a microarray analysis was undertaken on ovaries exposed to PMSG in vivo. The quality of RNA preparation was assessed and found to be good for further study .
The global expression profile of rat ovaries challenged with PMSG was compared with controls (without PMSG). Probe sets whose intensities were normalized and filtered, then were subjected to identifying significantly differentially expressed genes using t-test analysis by Table 2) . DE transcripts were involved in some important pathways. Including the estrogen-signaling pathway, MAPK signaling pathway and ovarian steroidogenesis, and ascorbate and aldrate metabolism (figure 5)
Differential Gene Expression Analysis
The functions and pathway analysis was done for the differentially regulated genes using DAVID database. Pairwise analysis of overall gene expression profiles between the 8 samples of immature female rat ovary of 26 to 28 days old rat was done. We found that 1904 genes were up regulated more than 1.5 fold and 1414 genes were found to be down regulated below 1.5 fold. Based on gene ontology study we have chosen some of the functionally important genes in oogenesis. It can be noticed that only the lactonase gene (Gulo) expression increased but not that of gene for L-GuDH ( Figure 6 ). No increase in gene expression levels of the gene for L-GuDH was observed. From current observations, it appears that actions of PMSG (FSH like) on specific activity of L-Gulonate-3-dehydrogenase and ascorbic acid content are independent phenomena and L-Gulonate -3-dehydrogenase may not have a role in the regulation of ovarian ascorbic acid content. Stabilization of mRNA for the GuDH and/or post-translational modification/activation of the GuDH could also have a played a role in total increase in the GuDH specific activity. Indeed there are reports that an mRNA population not involved in translation could be reactivated by cytoplasmic poly A polymerase (Weill et al. 2012) . There is also a possibility that in the case of ovaries exposed to PMSG, without increase in expression level of L-GuDH gene, the dormant mRNA got activated and hence we observed the increase in specific activity of the enzyme.? In fact bioinformatics studies have revealed potential phosphorylation sites in L-GuDH protein structure (Shah Saddad Hussainunpublished results). More research work needs to be done to throw light on this problem.
Hence it can be tentatively concluded that LH does not regulate this enzyme transcriptionally and FSH probably regulates this enzyme through post-transcriptional mechanisms.
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